Jörg Holenz

Title: Jörg Holenz: Innovator in Pharmaceutical Modulation

Introduction

Jörg Holenz is a notable inventor based in Bolton, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors in the brain. His work focuses on addressing various mental health and addiction issues through innovative chemical solutions.

Latest Patents

One of Jörg Holenz's key patents is titled "Halo-substituted piperidines as orexin receptor modulators." This patent relates to certain halo-substituted piperidine compounds, pharmaceutical compositions containing them, and methods of using these compounds. The applications of his invention include treating substance addiction, panic disorder, anxiety, post-traumatic stress disorder, pain, depression, seasonal affective disorder, eating disorders, and hypertension. He holds 1 patent in this area.

Career Highlights

Throughout his career, Jörg Holenz has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with AstraZeneca and Eolas Therapeutics, Inc. His experience in these organizations has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Jörg has collaborated with several talented individuals in his field. Some of his notable coworkers include Theodore M. Kamenecka and Steven Sigmund Wesolowski. Their combined expertise has likely enhanced the quality and impact of their work in pharmaceutical research.

Conclusion

Jörg Holenz is a distinguished inventor whose work in pharmaceutical modulation has the potential to improve the lives of many individuals facing mental health challenges. His innovative approaches and collaborations continue to pave the way for future advancements in the field.